Daly Richard J

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$90,002.27
Insider Sells Quantity
1
Insider Sells Sum
$276,734.93

Insider Activity of Daly Richard J

According to the SEC Form 4 filings, Daly Richard J, being in a position of

  1. President and CEO at Catalyst Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 17323 shares for $276,735,
    over all time since 2024-06-04, has bought 0 shares, and sold 17323 shares for $276,735.

The largest purchase of all time was on 2017-05-17 and amounted to 7500 shares of Palisade Bio, Inc. for $30,000.

The largest sale of all time was on 2024-06-04 and amounted to 17323 shares of Catalyst Pharmaceuticals, Inc. for $276,735.

Biography of Daly Richard J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$276,7351100

Comparison of Insiders on Amount of Buys and Sells

2024-06-04SaleCatalyst Pharmaceuticals, Inc.
CPRX
President and CEO
17,323
0.0146%
$15.97$276,735+29.8%
2017-05-17PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
7,500
0.0105%
$4.00$30,000-58.6%
2017-02-24PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
2,591
0.0039%
$3.86$10,001-50.26%
2017-01-25PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
2,841
0.0043%
$3.52$10,000-25%
2016-12-23PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
32,259
0.0037%
$0.31$10,000-14.04%
2016-11-25PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
35,715
0.0041%
$0.28$10,000+5.39%
2016-10-25PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
35,715
0.0041%
$0.28$10,000+10.6%
2016-09-23PurchasePalisade Bio, Inc.
PALI
Chief Executive Officer
31,250
0.0045%
$0.32$10,000-0.96%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.